HEADER PHOTORECEPTOR 13-OCT-06 2IQK TITLE BOVINE RHODOPSIN, METARHODOPSIN II MODEL COMPND MOL_ID: 1; COMPND 2 MOLECULE: RHODOPSIN; COMPND 3 CHAIN: A SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 3 ORGANISM_COMMON: BOVINE; SOURCE 4 ORGAN: EYE; SOURCE 5 TISSUE: RETINA; SOURCE 6 CELL: ROD KEYWDS PHOTORECEPTOR, G PROTEIN-COUPLED RECEPTOR, MEMBRANE PROTEIN, KEYWDS 2 RETINAL PROTEIN, VISUAL PIGMENT EXPDTA THEORETICAL MODEL AUTHOR I.D.POGOZHEVA,A.L.LOMIZE,H.I.MOSBERG REVDAT 1 24-OCT-06 2IQK 0 JRNL AUTH C.B.FOWLER,I.D.POGOZHEVA,A.L.LOMIZE,H.LEVINE, JRNL AUTH 2 H.I.MOSBERG JRNL TITL COMPLEX OF AN ACTIVE MU-OPIOID RECEPTOR WITH A JRNL TITL 2 CYCL PEPTIDE AGONIST MODELED FROM EXPERIMENTAL JRNL TITL 3 CONSTRAIN JRNL REF BIOCHEMISTRY V. 43 1579 6 JRNL REFN ASTM BICHAW US ISSN 0006-2960 REMARK 1 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NULL REMARK 3 AUTHORS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2IQK COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998 REMARK 100 REMARK 100 THIS ENTRY WAS DEPOSITED AT RCSB ON 13-OCT-2006. REMARK 100 THE RCSB ID CODE IS RCSB039893. REMARK 220 REMARK 220 EXPERIMENTAL DETAILS REMARK 220 EXPERIMENT TYPE : THEORETICAL MODELLING REMARK 220 REMARK 220 REMARK: THIS THEORETICAL MODEL ENTRY WAS NOT ANNOTATED AND NOT REMARK 220 VALIDATED BY THE WWPDB STAFF AND THEREFORE MAY NOT REMARK 220 CONFORM TO THE PDB FORMAT. REMARK 225 REMARK 225 THEORETICAL MODEL REMARK 225 THE COORDINATES IN THIS ENTRY REPRESENT A MODEL STRUCTURE. REMARK 225 PROTEIN DATA BANK CONVENTIONS REQUIRE THAT CRYST1 AND REMARK 225 SCALE RECORDS BE INCLUDED, BUT THE VALUES ON THESE REMARK 225 RECORDS ARE MEANINGLESS. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 327 REMARK 465 LEU A 328 REMARK 465 GLY A 329 REMARK 465 ASP A 330 REMARK 465 ASP A 331 REMARK 465 GLU A 332 REMARK 465 ALA A 333 REMARK 465 SER A 334 REMARK 465 THR A 335 REMARK 465 THR A 336 REMARK 465 VAL A 337 REMARK 465 SER A 338 REMARK 465 LYS A 339 REMARK 465 THR A 340 REMARK 465 GLU A 341 REMARK 465 THR A 342 REMARK 465 SER A 343 REMARK 465 GLN A 344 REMARK 465 VAL A 345 REMARK 465 ALA A 346 REMARK 465 PRO A 347 REMARK 465 ALA A 348 SEQRES 1 A 348 MET ASN GLY THR GLU GLY PRO ASN PHE TYR VAL PRO PHE SEQRES 2 A 348 SER ASN LYS THR GLY VAL VAL ARG SER PRO PHE GLU ALA SEQRES 3 A 348 PRO GLN TYR TYR LEU ALA GLU PRO TRP GLN PHE SER MET SEQRES 4 A 348 LEU ALA ALA TYR MET PHE LEU LEU ILE MET LEU GLY PHE SEQRES 5 A 348 PRO ILE ASN PHE LEU THR LEU TYR VAL THR VAL GLN HIS SEQRES 6 A 348 LYS LYS LEU ARG THR PRO LEU ASN TYR ILE LEU LEU ASN SEQRES 7 A 348 LEU ALA VAL ALA ASP LEU PHE MET VAL PHE GLY GLY PHE SEQRES 8 A 348 THR THR THR LEU TYR THR SER LEU HIS GLY TYR PHE VAL SEQRES 9 A 348 PHE GLY PRO THR GLY CYS ASN LEU GLU GLY PHE PHE ALA SEQRES 10 A 348 THR LEU GLY GLY GLU ILE ALA LEU TRP SER LEU VAL VAL SEQRES 11 A 348 LEU ALA ILE GLU ARG TYR VAL VAL VAL CYS LYS PRO MET SEQRES 12 A 348 SER ASN PHE ARG PHE GLY GLU ASN HIS ALA ILE MET GLY SEQRES 13 A 348 VAL ALA PHE THR TRP VAL MET ALA LEU ALA CYS ALA ALA SEQRES 14 A 348 PRO PRO LEU VAL GLY TRP SER ARG TYR ILE PRO GLU GLY SEQRES 15 A 348 MET GLN CYS SER CYS GLY ILE ASP TYR TYR THR PRO HIS SEQRES 16 A 348 GLU GLU THR ASN ASN GLU SER PHE VAL ILE TYR MET PHE SEQRES 17 A 348 VAL VAL HIS PHE ILE ILE PRO LEU ILE VAL ILE PHE PHE SEQRES 18 A 348 CYS TYR GLY GLN LEU VAL PHE THR VAL LYS GLU ALA ALA SEQRES 19 A 348 ALA GLN GLN GLN GLU SER ALA THR THR GLN LYS ALA GLU SEQRES 20 A 348 LYS GLU VAL THR ARG MET VAL ILE ILE MET VAL ILE ALA SEQRES 21 A 348 PHE LEU ILE CYS TRP LEU PRO TYR ALA GLY VAL ALA PHE SEQRES 22 A 348 TYR ILE PHE THR HIS GLN GLY SER ASP PHE GLY PRO ILE SEQRES 23 A 348 PHE MET THR ILE PRO ALA PHE PHE ALA LYS THR SER ALA SEQRES 24 A 348 VAL TYR ASN PRO VAL ILE TYR ILE MET MET ASN LYS GLN SEQRES 25 A 348 PHE ARG ASN CYS MET VAL THR THR LEU CYS CYS GLY LYS SEQRES 26 A 348 ASN PRO LEU GLY ASP ASP GLU ALA SER THR THR VAL SER SEQRES 27 A 348 LYS THR GLU THR SER GLN VAL ALA PRO ALA MODRES 2IQK ASN A 2 ASN GLYCOSYLATION SITE MODRES 2IQK ASN A 15 ASN GLYCOSYLATION SITE HET NAG G1335 14 HET NAG G1336 14 HET BMA G1337 11 HET NAG G1338 14 HET NAG G1339 14 HET BMA G1340 11 HET RET R 301 20 HET PLM Z1333 17 HET PLM Z1334 17 HETNAM NAG N-ACETYL-D-GLUCOSAMINE HETNAM BMA BETA-D-MANNOSE HETNAM RET RETINAL HETNAM PLM PALMITIC ACID HETSYN NAG NAG FORMUL 2 NAG 4(C8 H15 N O6) FORMUL 2 BMA 2(C6 H12 O6) FORMUL 4 RET C20 H28 O FORMUL 5 PLM 2(C16 H32 O2) HELIX 1 1 GLU A 33 HIS A 65 1 33 HELIX 2 2 THR A 70 GLY A 89 1 20 HELIX 3 3 GLY A 90 GLY A 101 1 12 HELIX 4 4 PHE A 105 CYS A 140 1 36 HELIX 5 5 GLY A 149 ALA A 169 1 21 HELIX 6 6 PRO A 170 VAL A 173 5 4 HELIX 7 7 ASN A 199 HIS A 211 1 13 HELIX 8 8 PHE A 212 GLN A 238 1 27 HELIX 9 9 GLN A 244 TRP A 265 1 22 HELIX 10 10 TRP A 265 HIS A 278 1 14 HELIX 11 11 PRO A 285 THR A 297 1 13 HELIX 12 12 THR A 297 ASN A 310 1 14 HELIX 13 13 ASN A 310 CYS A 323 1 14 SHEET 1 A 2 THR A 4 GLU A 5 0 SHEET 2 A 2 TYR A 10 VAL A 11 -1 O VAL A 11 N THR A 4 SHEET 1 B 2 TYR A 178 GLU A 181 0 SHEET 2 B 2 SER A 186 ILE A 189 -1 O GLY A 188 N ILE A 179 SSBOND 1 CYS A 110 CYS A 187 LINK ND2 ASN A 2 C1 NAG G1338 LINK ND2 ASN A 15 C1 NAG G1335 LINK O4 NAG G1335 C1 NAG G1336 LINK O4 NAG G1336 C1 BMA G1337 LINK O4 NAG G1338 C1 NAG G1339 LINK O4 NAG G1339 C1 BMA G1340 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MASTER 55 0 9 13 4 0 0 6 0 0 0 27 END